feed,title,long_url,short_url
Benzinga,Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma,https://www.benzinga.com/pressreleases/20/12/n18709638/intec-pharma-announces-cannabinoid-research-collaboration-with-gw-pharma,https://j.mp/2K67mTk
Benzinga,Prospect Capital Purchases $29 Million of First Lien Senior Secured Floating Rate Notes Issued by Thermal Production Solutions,https://www.benzinga.com/pressreleases/20/12/g18709627/prospect-capital-purchases-29-million-of-first-lien-senior-secured-floating-rate-notes-issued-by-t,https://j.mp/37KsWFi
Benzinga,POINT Biopharma Announces New Board Appointments,https://www.benzinga.com/pressreleases/20/12/g18709623/point-biopharma-announces-new-board-appointments,https://j.mp/2VSG5qe
Benzinga,Medicenna Announces Oral Presentation at the 2nd Annual Glioblastoma Drug Development Summit,https://www.benzinga.com/pressreleases/20/12/g18709622/medicenna-announces-oral-presentation-at-the-2nd-annual-glioblastoma-drug-development-summit,https://j.mp/2VSVsPk
Benzinga,Applied Therapeutics Announces MRS Data from ACTION-Galactosemia Study,https://www.benzinga.com/pressreleases/20/12/g18709615/applied-therapeutics-announces-mrs-data-from-action-galactosemia-study,https://j.mp/2LmDm6n
Benzinga,Fulcrum Therapeutics to Host Virtual Key Opinion Leader Event Featuring FTX-6058 for Sickle Cell Disease,https://www.benzinga.com/pressreleases/20/12/g18709611/fulcrum-therapeutics-to-host-virtual-key-opinion-leader-event-featuring-ftx-6058-for-sickle-cell-d,https://j.mp/37Mu6Qt
